The Boston Globe reports on the news that Massachusetts General Hospital has completed the first U.S. application of denovoSkin™, the bi-layer bioengineered skin graft developed by CUTISS, on a young pediatric patient. The reconstructive surgery was performed by Dr. Jeremy Goverman under FDA compassionate use.
Dr. Goverman describes the full-thickness personalized skin graft as a step closer to the “Holy Grail” of reconstructive surgery, potentially transforming skin surgery for both pediatric and adult patients.
Read the article here.
